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1.0 Abstract 
 Humans are exposed to a variety of toxic substances in their day-to-day activities that 
may have adverse health effects if not properly identified. An integrated dual-mode instrument 
that combines grating-coupled surface plasmon resonance (GCSPR) and grating-coupled surface 
plasmon coupled emissions (GCSPCE) should allow for the efficient detection of toxic analytes 
in a high-content system using gold-coated superparamagnetic nanobeads. The goal of this study 
is to validate the binding characteristics of the reagents intrinsic to this innovative assay 
methodology. Competition enzyme-linked immunosorbent assays (ELISA) and surface plasmon 
resonance (SPR) assays were conducted on NNK toxicants and SEB toxins, which were the 
prototype toxicant and toxin being analyzed.  
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2.0 Introduction 
 The prevalence of foreign antigens ingested by the human body has become an issue of 
great concern for the Food and Drug Administration [1]. Many of the products at local 
supermarkets come with warning labels, cleanly printed tags that list exactly which chemicals are 
included in the item’s biochemical makeup. However, humans come into contact with a variety 
of toxic substances in their day-to-day activities that cannot be so easily identified. Such 
materials may have adverse influences on the human physiology that can only be treated if 
properly identified [2]. Ciencia, Inc and the laboratory group of Dr. Michael Lynes have 
developed an integrated dual-mode instrument that combines grating-coupled surface plasmon 
resonance (GCSPR) and grating-coupled surface plasmon coupled emissions (GCSPCE) in a 
manner that should allow for more efficient detection of toxic analytes in a high-content system. 
The instrument system enables the simultaneous measurement of thousands of different analytes 
in a single sample. Diagnostic processes are expedited by efficient detection mechanisms that 
can identify toxic agents. The novel technology will allow for simultaneous, rapid, efficient and 
cost-effective detection of a broad range of toxic analytes that humans might encounter in their 
everyday environment. The intention of this study is to validate the binding relationship of the 
reagents intrinsic to this innovative assay methodology.  
 The hybridization of GCSPR and GCSPCE technology will improve detection methods 
of small analytes as compared to current SPR technologies. Label-based methods, for example, 
can compromise protein function and therefore result in erroneous data [6]. Specific protein-
binding molecules can be immobilized upon GCSPR sensor chips. Illumination of the chip by 
light of the proper wavelength, angle of incidence and polarization will cause energy from the 
incident light to couple with electrons of the gold metal coating [6]. The coupling creates what is 
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known as a surface plasmon at the metal-dielectric interface. Binding events that occur at the 
surface of the gold-coated chip will cause a shift in the SPR angle, which can be measured by a 
CCD camera as an indication of binding. SPR measures binding of unlabeled proteins to the 
immobilized, specific protein-binding molecules; GCSPR can therefore detect protein binding at 
the sensor surface [6]. 
 GCSPCE is a fluorescent protein microarray technology that has higher sensitivity than 
similar assays. The surface plasmons generated at the metal-dielectric interface provide 
directional excitation to fluorophores positioned within 200 nm of the chip surface [7]. The 
strength of the excitation field results in an increase in fluorescent signal when compared to 
standard fluorescent immunoassays. GCSPCE can therefore effectively detect binding within 
regions of interest printed upon a gold-coated chip [7].  
 The novel GCSPR/GCSPCE technology employs spatially encoded capture molecules 
specific to a single analyte type. Therefore, this technology can be used to determine if a certain 
analyte is present in a sample. The novel GCSPR/GCSPCE technology will allow for the 
simultaneous detection of multiple toxins and toxicants in a cheaper and less labor-intensive 
manner than current label-based immunoassays. The integrated GCSPR/GCSPCE dual-mode 
instrument employs superparamagnetic nanobeads that boost the signal typically acquired 
through SPR assays, enabling the simultaneous measurement of thousands of different analytes 
in a single sample.  
 Differing configurations of the analytes and antibodies on the sensor chip surface versus 
the nanobead surface enhance the signal retrieved during SPR assays, indicating the binding 
between reagents (Figure 4). The dual mode nature of this technology should allow for a large 
dynamic range with high sensitivity and a low limit of detection [7]. 
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 The toxic analytes studied are categorized as substances that can be easily spread among 
individuals and into the human environment. Toxins are poisonous substances generated by 
living cells. Toxicants, however, are forms of poison that are created by humans and introduced 
by their activity into the surrounding environment. Cigarette smoke is a complex mixture of 
toxicants and it is known to contain a variety of dangerous carcinogens that can be exhaled into 
the environment [2]. Humans can come into contact with these carcinogens, specifically 
benzo(a)pyrene (B(a)P) and nicotine-derived nitrosasmine ketone (NNK), either by smoking the 
cigarettes themselves or through second-hand inhalation of the toxic smoke [2].  NNK is a 
metabolite of nicotine and B(a)P is a product of combustion. SEB is produced by the gram-
positive bacteria Staphylococcus aureus and is an enterotoxin with pathological effects on the 
human body. The toxicants (B(a)P and NNK) and toxins (SEB) studied were selected because of 
their relevance to human health. 
 Mechanisms of toxic action can follow either non-specific or specific mechanisms [10]. 
Non-specific modes of toxic action cause narcosis, the generalized and broad-sweeping 
depression of biological activity that results from toxic exposure.  A mechanism of toxic action is 
considered specific when the toxins or toxicants modify physiological processes by binding to a 
specific site at low concentrations. Specific modes of toxic actions include uncouplers of 
oxidative phosphorylation (which prevent ATP production), respiratory blockers and irritants 
that inflame tissue at the site of contact [10]. 
 Small molecules cannot be directly detected because SPR technology measures mass, and 
the small molecules contribute little on a molar basis. The competition approach to these 
GCSPR/GCSPCE assays may therefore improve the current limits of detection. This study 
developed measurements for NNK and SEB in order to validate the essential binding relationship 
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between these antigens and their antibodies. In order to do so, a standard curve was generated of 
the detection of these two substances using a reference “gold standard” technology acting as a 
basis for comparison. This comparison technology was an ELISA-based detection. While an 
ELISA-based detection determines the presence of binding between one specific 
antibody/antigen pair through color-changing enzymes read in microtiter plates (Figure 11), an 
SPR approach allows for the detection of multiple antibody/antigen pairings through label-free 
platforms [6]. 
 
2.1 Small Analytes 
 
 2.1.1 NNK 
  4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (Figure 1) is a tobacco-specific 
nitrosamine (TSNA) known as NNK [3]. NNK can be metabolized to form the derivative N-
NAL, which can be detected in smokers’ urine and plasma samples [2]. Animal studies have 
proven that NNK is one of the most potently carcinogenic substances of the TSNA family. P-450 
mediated α-hydroxylation reactions involving NNK create electrophiles able to interact with 
DNA and other crucial macromolecules, leading to carcinogenic products [3].   
 Covalent modification of DNA induces irreparable mutations in the genome that can 
cause malfunctioning repair processes and uncontrolled DNA replication during the cell cycle’s 
S-phase [3]. Exposure to NNK can therefore predispose contaminated cells to tumorigenesis.  
  
 2.1.2 SEB 
 Staphylococcal enterotoxin B (Figure 2) is an enterotoxin produced by Staphylococcus 
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aureus, a gram-positive bacteria. Exposure to SEB is known to promote the initiation of immune 
disorders in human intestines [9]. SEB can be found in food that, upon ingestion by humans, 
leads to classic food poisoning symptoms such as severe diarrhea, nausea and cramping. The 
immune system will release a massive amount of cytokines in response to SEB exposure, 
resulting in severe inflammation of the human body.  SEB can also result in a potentially fatal 
illness known as toxic shock syndrome.  
 
 2.1.3 B(a)P 
 Benzo(a)pyrene (Figure 3) is a polycyclic aromatic hydrocarbon  that is a product of 
combustion and is most often associated with human exposure as a consequence of smoking 
tobacco [2,4]. Exposure to B(a)P has been shown to cause DNA damage similar to that of NNK. 
B(a)P’s mutagenic effects have been proven on somatic cells and several environmental 
protection agencies have registered B(a)P as a reproductive toxicant. Benzo(a)pyrene 
diolepoxide (BPDE-DNA), a diol epoxide adduct, levels increase with B(a)P metabolism, which 
cause DNA breaks during attempts to excise and repair the areas of mutation in exposed cells. 
Direct genotoxicity can also increase from the production of reactive oxygen species that is 
attributed to B(a)P exposure [5].   
 
2.2 Detection Methods 
  
 2.2.1 ELISA 
 An enzyme-linked immunosorbent assay (ELISA) is a high sensitivity detection method 
[7]. In a sandwich ELISA, specific antibodies will coat the surface of a polystyrene well and can 
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subsequently capture the cognate analyte. A second antibody is then added to the wells so that 
the analyte is bound on either side, forming a “sandwich.” This secondary antibody will be 
coupled to an enzyme marker that causes a substrate to change color in proportion to the amount 
of analyte in the well [8]. Antibodies with the proper binding sites will enable specific capture of 
the analyte in the solution.  
 In order to evaluate the proper antibody sets for B(a)P and NNK, reagent validation was 
performed using ELISA and standard curves were generated. The ELISA method employs 
immobilizing antibodies that will bind their cognate analytes when mixed in separate wells; if the 
antibodies selected work with ELISA, then it is reasonable to assume that the same antibodies 
will work in SPR. A standard curve produced by the ELISA assay will verify that the proper 
binding occurred between antibodies and their cognate antigens. Once the limits of detection 
(LOD) and the sensitivity have been determined by ELISA, implementation of the SPR 
technology can begin. The antibodies will only be able to detect certain concentrations of analyte 
[8]. These values can then be used on the surface-bound receptors of the SPR to investigate what 
concentrations of the analyte must be present in the sample for the technology to detect it.  
 
 2.2.2 SPR 
 The GCSPR/GCSPCE integrated technology functions more effectively than current SPR 
measuring devices. SPR, or surface plasmon resonance, is the oscillation that occurs when 
valence electrons are stimulated by light. A grating-coupled surface plasmon resonance 
(GCSPR) sensor chip employs a layer of gold on a diffraction grating and a variety of 
immobilized specific capture molecules arranged in regions of interest (ROIs) on the gold 
surface [6]. When this chip is exposed to light of the appropriate wavelength, phase velocity, and 
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angle, the electrons of the metal will become excited as “surface plasmons.” As this coupling of 
light to the electrons occurs at the surface of the chip, the amount of reflected light decreases in 
proportion to the energy transferred to the plasmons. Proteins that may bind to the surface of the 
chip affect the local refractive index and thus the angle at which this coupling occurs. SPR can 
therefore be used to measure analyte-binding to surface-bound capture molecules, which can be 
monitored with an imaging detector known as a charge-coupled device (CCD) camera [6].  
 The introduction of gold-coated superparamagnetic nanobeads should increase the signal 
typically acquired through SPR assays by boosting the mass change that occurs after binding 
between the antibodies and their cognate antigens. The antibodies may be conjugated to the chip 
and the analytes conjugated to nanobeads or vice versa (Figure 4). These configurations should 
ultimately yield a more effective diagnostic tool for use in instances of toxic exposure.  
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3.0 Materials and Methods  
  
 3.1 BCA Protein Assay 
 NNK, anti-NNK, NNK conjugated to BSA and NNK conjugated to ovalbumin were 
generously provided by Dr. Lawrence Silbart and Dr. Amy Howell. The BCA protein assay 
(using PierceTM BCA Protein Assay Kit) was run to determine the concentrations of NNK-OVA 
and NNK-BSA. The BCA assay relies on the reduction of copper ions in an amount proportional 
to the quantity of protein found in solution. Comparing the absorption spectra of the unknown 
samples to known standards indicated the amount of protein present in solution. A dilution series 
of known albumin standards was added to separate wells in the microtiter plate, and compared to 
10 ul of NNK-ova, 10 ul of 1:10 dilution of NNK-ova, 10 ul NNK-BSA and 10 ul of 1:10 
dilution of NNK-BSA. BCA working reagents were then made in a ratio of 1:50 and added to 
each well. The absorption spectrum was measured at 560 nm. This assay was also used to 
determine the concentration of SEB aliquots using 10 ul of SEB and 10 ul of 1:10 dilution of 
SEB. 
 
 3.2 Titration ELISA 
 Titration ELISAs were done to determine the proper concentration of NNK reagents to 
use in subsequent SPR assays. The titration began by coating Immulon 2 HB plate with 10 ug/ml 
of  NNK, NNK-OVA or NNK-BSA and incubating for 1 hour at 37°C. The plates were washed 
and then blocked with 2% BSA. The plate was then incubated for 1.5 hours at 37°C and then 
washed again. The primary antibody dilution series began by mixing 20.8 ul of NNK antibody in 
629.2 ul of binding buffer (0.25 g BSA in 100 ml PBST). 100 ul of each dilution was then added 
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across the columns of wells. The plate was incubated for 1 hour at 37°C and then washed. The 
secondary antibody (Goat anti-mouse Ig-AP 10.8) was mixed with binding buffer, incubated on 
plate for 1 hour at 37°C and then washed. P-nitrophenyl phosphate (PNPP) tablets were 
dissolved in substrate buffer and 100 ul were added to each well. The absorption spectrum was 
then read kinetically at 450 nm across 10 minutes. The experiment was repeated with SEB and 
anti-SEB reagents in order to determine the proper concentration of SEB for use in subsequent 
SPR assays. 
   
 3.3 SPR 
 Reagents included 95% ethanol and ultrapure H2O (18 mΩ). Spotting was done with the 
SpotBot II Automated Spotting System (ArrayIt Microarray Technology) on gold 
GCSPRI/SPCE dual mode sensor chips provided by Ciencia, Inc. 384 well low-protein binding 
V bottom Microplates were purchased from ThermoScientific, Inc. Capture antibody to be 
immobilized on sensor chips was dissolved in PBS. 
 
  3.3.1 Preprinting of Sensor Chip 
  Aliquots of capture and control antibodies were added to wells of a 384 well 
microplate. The plate was then covered with adhesive foil and spun at 500 rpm for 4 minutes at 
4°C to ensure all liquid had reached the bottom of the wells. Gold sensor chips were rinsed with 
95% ethanol and H2O (18mΩ) for 10 seconds each. Chips were then dried using pressurized 
filtered air and placed in a plastic petri dish, leaving the coated gold surface facing up. 
Nonspecific absorption occurred between reagents and the chip surface. 
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  3.3.2 Preparing the Robotic Spotter 
  The wash buffer, vacuum and humidity of spotting apparatus were activated. A 
new spotting procedure was built that designated for printing the number of required replicates 
onto the sensor chip. The pin head was removed from the machine using gloves and washed with 
95% ethanol and then sonicated in H2O (18 mΩ) and dried with pressurized filtered air. The pin 
was studied under 10x magnification of microscope to ensure that it was clean. The plate was the 
placed into the spotting machine.  
 
  3.3.3 Sensor Chip Printing 
  The chips were washed with H2O (18 mΩ) for 10 seconds and pressurized filtered 
air was used to dry them. The chips were inserted into the spotting apparatus. Once the spotting 
had finished, the plate and the spotting pin were removed. The wash, vacuum, and sonication 
components of the spotting machine were deactivated. The chips were incubated in a humid 
environment for approximately 1 hour and then stored at 4°C in the dark for up to two weeks. 
 
  3.3.4 Competition Assay 
  Each chip was blocked with 2% bovine serum albumin (BSA) for thirty minutes.  
In separate experiments, a dilution series starting with a 1:32.5 dilution of SEB antibody and 
NNK antibody were incubated with 10 ug/ml of free SEB or free NNK, respectively, for thirty 
minutes for use in the competition chambers. Uncompeted SEB or NNK was added to the other 
chamber on the dual chamber SPR chip. Both chambers were washed with PBST three times and 
then incubated with goat anti-mouse IgG-Alexa 647 at 2 ug/ml. The chips were then washed 
three times with PBST and read fluorescently with an exposure of five seconds.  
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4.0 Results 
  
 4.1 BCA Results 
 NNK-BSA was found to be at a concentration of 1.1075 mg/ml. NNK-OVA was found to 
be at a concentration of 0.605 mg/ml. SEB was found to be at a concentration of 0.327 mg/ml 
(Figure 5).   
  
 4.2 Titration ELISA Results 
 The results of the BCA identified the concentration of the NNK-ova and NNK-BSA 
solutions, but the concentration of the NNK antibody was still unknown. Titrations produced a 
curve that ranged from 1:62.5 to 1:6400 doubling dilutions. The titrations allowed for the 
determination of the dilution factor that will be most effective in subsequent SPR assays (Figure 
6). 
 The laboratory of Dr. Michael Lynes had access to four separate sources of secondary 
antibody (Goat anti-mouse Ig-AP 10.8). A titration was performed to determine which vial gave 
the highest signal on the plate reader and should therefore be used in all titrations of NNK and 
SEB. Tube 3 was found to give the highest reading and was therefore used in subsequent 
titrations (Figure 7). 
 Titrations were performed using purchased SEB and SEB antibody (Figure 8). Neither 
titration formed a typical titration curve, but instead dropped off where it would typically 
plateau. When graphed on log scale, both graphs showed a distinct peak at 1:1000 dilution of 
SEB antibody. 
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 4.3 SPR Results 
 A two chamber gasket was used on the chip in order to test the competition between 
NNK-OVA/NNK-BSA conjugated to the chip versus free NNK flowed over the chip. Each ROI 
showed significant competition with free NNK (Figure 9).  The fluorescent units per second 
exposure sharply decreased when competing with free NNK.  
 A similar assay was conducted that competed  free SEB with SEB preincubated with SEB 
antibody. Each ROI also showed significant competition with free SEB (Figure 10). The 
fluorescent units per second exposure sharply decreased when competing with free SEB. 
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5.0 Discussion 
 The results of the BCA identified the concentration of the NNK-OVA and NNK-BSA 
solutions, but the concentration of the NNK antibody was still unknown. The solution of NNK-
antibody provided by Dr. Silbart was a mixture of antibody and tissue culture media 
supplemented with fetal bovine serum proteins; the presence of irrelevant proteins in the NNK-
antibody sample required that it be regarded in terms of relative dilution factor, and not absolute 
concentration. The titrations would allow for the determination of which dilution factor will be 
most effective in subsequent SPR assays. Furthermore, the titration allowed for the construction 
of a curve to examine the activity at a range of concentrations. The shape of these curves is 
indicative of effective binding between antibodies and their antigens. The titrations therefore 
demonstrated that the NNK-antibody was effectively binding the NNK analytes when tested in 
polystyrene wells and would likely do the same on the SPR chip (Figure 6). 
 The NNK-OVA and NNK-BSA yielded curves when titrated. However, the NNK (which 
was not conjugated to a large protein) yielded relatively flat lines that did not form the expected 
curves. The unconjugated NNK failed to bind effectively to the plate, though the reason for this 
failure is unclear. It is understood that the large ovalbumin and bovine serum albumin proteins 
are able to bind effectively to the polystyrene well (Figure 11). The larger proteins will bind to 
the well and present the NNK analyte to the primary antibody.  
 The SPR data revealed that competition assays can be successfully performed on an SPR 
chip using the NNK-OVA and NNK-BSA reagents. The presence of free NNK significantly 
reduced the resulting signal, indicating that the proper binding between antibody and antigen was 
occurring.  
 The SEB titrations did not form typical curves when titrated. The curves would begin 
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sloping upwards and then drop steadily down where it would normally plateau. The drop in the 
curve was likely caused by nonspecific-binding; the primary antibodies may have bound to the 
well instead of the SEB antigens. Furthermore, inefficient hand washing with PBST may have 
left some unbound primary antibody in the wells, allowing the secondary antibodies to bind 
nonspecifically. Nevertheless, a distinct peak was visible at the 1:1000 dilution factor, indicating 
the optimal dilution for use in subsequent SPR assays.  
 The SPR data performed with the SEB reagents gave results similar to the SPR assays 
performed using NNK reagents; competition assays can be successfully performed on an SPR 
chip using the SEB reagents. Binding between the SEB antibody and the SEB antigen did occur 
because the presence of free SEB significantly reduced the resulting signal. The SPR data of both 
the SEB and NNK reagents showed high signals even at the lowest dilutions, indicating that far 
lower concentrations of the small molecules could be detected using this integrated technology. 
 In the future, configuring NNK reagents using the superparamagnetic nanobeads should 
efficiently yield even more distinct readings because of the increase in mass. The steep increase 
will affect the dialectic interface of the SPR assay in such a way as to give even more prominent 
readings.  
 B(a)P reagents still need to be validated through titrations and SPR assays. B(a)P, 
similarly to the titrations of unconjugated NNK, failed to bind effectively to the plate during 
initial titrations. It is theorized that the small size of B(a)P and NNK render it unable to grip the 
polystyrene well, though other possibilities still exist. B(a)P reagents that are conjugated to 
larger proteins (in such a way as the NNK reagents are conjugated to ovalbumin and bovine 
serum albumin) are required before B(a)P titrations can proceed. 
 The heightened sensitivity of the integrated GCSPR/GCSPCE technology surpasses that 
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of typical SPR and ELISA based detections, holding potential for improved utility in the medical 
field. A more effective understanding of the binding relationships between antibodies and their 
antigens allows for expedited and more thorough diagnostic methodologies. Point-of-care testing 
(POCT), for example, can be enhanced through the implementation of this novel integrated 
technology. POCT is simple blood tests performed at a patient’s bedside and often involves 
transportable or handheld instruments. Widespread use of the integrated GCSPR/GCSPCE 
technology could allow for more effective diagnoses of patients afflicted with toxic exposures. A 
patient would be able to provide a blood sample to a medical practitioner, who could then 
introduce the sample into the integrated SPR technology and verify which toxin or toxicant was 
affecting the patient. The integrated GCSPR/GCSPCE technology has immense potential to 
revolutionize the medical field of toxic detection methodologies.  
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Figures 
 
FIGURE 1. NNK Structure. Nicotine-derived nitrosasmine ketone (NNK) is present in tobacco 
products and acts as an exceptionally powerful carcinogen. It is an aromatic compound and a 
yellow, crystalline solid with a molecular weight of 207.23 g/mol. 
Figure 2. SEB Structure. Staphylococcal enterotoxin B (SEB) has a molecular weight of 28 kD 
and contains 239 amino acids residues [11]. SEB has two domains with complex tertiary 
structures that allows SEB to become resistance to proteases such as trypsin and papain.  
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 FIGURE 3. B(a)P Structure. Benzo(a)pyrene is an aromatic hydrocarbon with a molecular 
weight of 252.31 g/mol. Its bulky shape can inflict serious damage to exposed DNA. 
 
 
 
 
 
 
 
 
 
 
FIGURE 4. Improvement of analyte detection. The left panel displays ROIs populated by 
antibodies (Y1 and Y2) with each analyte (T1 and T2) coupled to the gold nanobead surface. The 
right panel shows the antibodies coupled to the nanobead surface while the analytes have been 
immobilized upon the sensor chip surface.  
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FIGURE 5 A. BCA of NNK-OVA, NNK-BSA and SEB. NNK-BSA was found to be at a 
concentration of 1.1075 mg/ml and NNK-OVA was found to be at a concentration of 0.605 
mg/ml through BCA. SEB was found to be at a concentration of 0.327 mg/ml.  
 
 
 
 
 
FIGURE 5 B. Standard curve of BCA for NNK-OVA and NNK-BSA. The above curve was 
generated from the albumin standards used in the BCA of the SEB aliquots. 
 
 
 
 
 
FIGURE 5 C. Standard curve of BCA for SEB aliquots. The above curve was generated from 
the albumin standards used in the BCA of the SEB aliquots. 
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FIGURE 6. Titration of NNK, NNK
NNK-OVA  and NNK-BSA, each at 10 ug/ml. The plate was blocked with 200 ul/ well of 2% 
BSA. A dilution series of primary NNK antibody was added across all rows. Secondary antibody 
(Goat anti-mouse Ig-AP 10.8) was 
was added across all rows. The plate was read kinetically at 405 nm for 10 minutes.
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FIGURE 7. Titration of Goat anti-mouse Ig-AP 10.8. All 10.8 antibody tubes were collected; 
they were numbered 1, 3, 4 and 5. 1000 ul of PBS was mixed with 1 ul of each of the four 
antibodies (one from each set) and then made into four series of doubling dilutions. 100 ul of 
each tube in each series was put into a well and incubated in Immulon 2 HB plate for 1 hour at 
37°C. The plate was washed. Two PNPP tablets were dissolved in 10 ml of substrate buffer and 
100 ul was added to each well. The plate was read at 405 nm for 10 minutes with a 37 second 
interval. 
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FIGURE 8. 123 ul of SEB aliquots (each at a concentration of 0.327 mg/ml) was mixed with 
3877 ul of coating buffer to yield a solution of 10 ug/ml. Three rows of Immulon 2 HB plate 
were coated with 100 ul of solution and then incubated 1 hour at 37°C. The plate was washed 
and blocked with 200 ul/well of 2% BSA. Dilution series of SEB antibody, starting with a 1:32.5 
dilution and going down by half, was made in binding buffer and 100 ul from each tube was 
added down the three rows.  The wells were incubated for 1 hour at 37°C. 100 ul of secondary 
antibody (Goat anti-mouse Ig-AP 10.8) was added to each well and incubated for 1 hour at 37°C. 
PNPP tablet was dissolved in 5 ml of substrate buffer  and 100 ul was added to each well.  The 
plate was read at 405 nm for 10 minutes with a 37 second interval. 
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FIGURE 9. Significant competition with free NNK on an SPR chip. There was significant 
competition between NNK-OVA and NNK-BSA with free NNK on chip. Free NNK was able to 
compete the binding between NNK antibody and NNK conjugated to the chip. For competition, 
free NNK was preincubated with 1:160 dilution of monoclonal NNK antibody for 1 hour. The 
competed and uncompeted NNK antibodies were added to the chip. The chip was incubated with 
goat anti-mouse IgG-Alexa 647 at 2 ug/ml. The chip was washed with PBST and read under FL 
mode for 5 seconds exposure. **P = < 0.01; ***P = < 0.0005; ****P = < 0.0001 
Wbo031214 
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FIGURE 10. Significant competition with free SEB on an SPR chip. There was significant 
competition between SEB and SEB antibody at all concentrations. Free SEB was able to 
compete the binding between SEB antibody and SEB conjugated to the chip. The chip was 
blocked with 2% BSA for 30 minutes. For competition, free SEB was preincubated with 1:500 
dilution of monoclonal SEB antibody for 1 hour. The competed and uncompeted SEB antibodies 
were added to the chip. The chip was incubated with goat anti-mouse IgG-Alexa 647 at 2 ug/ml. 
The chip was washed with PBST and read under FL mode for 5 seconds exposure. **P = < 0.01; 
**** P < 0.0001. 
Wbo041614 
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FIGURE 11. Configuration of titration ELISAs. In Well 1, the NNK analyte binds to the plate 
at an undetectable level. The large ovalbumin in Well 2 and bovine serum albumin in Well 3 
bind to the plate and present the conjugated NNK analyte to the primary NNK antibody. The 
anti-NNK is followed by a secondary antibody (Goat anti-mouse Ig-AP 10.8) that is conjugated 
to an enzyme. Well 4 served as a blank and did not receive any NNK analytes. 
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